For patients over 60 on HRT, most providers recommend lab work every 6-12 months once levels are stable — and more frequently after any dose change. The panel should include hormones (estradiol, testosterone, progesterone), metabolic markers (CBC, CMP, lipids), and age-appropriate screening (PSA for men, breast imaging for women as recommended).
Age does not change the fundamental principle of HRT monitoring — regular labs are essential at any age. However, patients over 60 may need more comprehensive panels and closer attention to certain markers.
Recommended frequency:
- After starting or changing dose: Labs at 6-8 weeks to confirm levels are where they should be
- Once stable: Every 6-12 months, depending on your provider’s preference and your individual risk factors
- If symptoms change: Labs sooner rather than later — new symptoms on a previously stable protocol may indicate a dose adjustment is needed or another issue is developing
What to include in the panel:
- Hormones: Estradiol, progesterone (if applicable), total and free testosterone, SHBG, DHEA-S
- Thyroid: TSH, free T3, free T4 — thyroid function can shift with age independent of HRT
- Metabolic: CBC (including hematocrit), comprehensive metabolic panel, fasting lipids, fasting glucose or HbA1c
- For men: PSA — standard screening on TRT at any age, but especially important over 60
- For women: Continue recommended breast cancer screening per your provider’s guidance
- Bone density: DEXA scan periodically, as HRT plays a role in bone health
Why over-60 monitoring matters more, not less: As we age, kidney and liver function can change, cardiovascular risk factors accumulate, and the body’s response to medications can shift. HRT at 60+ is safe and effective for many people — but it requires attentive monitoring to stay that way.